DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...
Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by ...
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...
It is hoped the "groundbreaking" device will help improve treatment options for people with eczema, as STV Reporter Amie Flett reports. For years, people living with ...
Hosted on MSN
DexCom extends drop to reach five-month low
Shares of DexCom (NASDAQ:DXCM) fell for the third straight session on Friday to reach the lowest level since April, even as the continuous glucose monitoring (CGM) equipment maker managed to retain ...
Digital Camera World on MSN
“My Nikon Z8’s sensor is filthy – I had no idea it had a sensor shield!” Here’s how to make sure yours is switched on
Make sure you don’t make the same mistake by ensuring your Nikon Z8 or Z9’s sensor shield is active BEFORE you change lenses ...
Vice-Chancellor of University of Agricultural Sciences (UAS) Raichur M. Hanumanthappa has said that if postgraduate students develop discipline and commitment and carry out research, farmers in ...
Medtech leaders with varying degrees of experience have offered a range of advice in terms of leadership at the helm of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback